ESA Biosciences, a Magellan Biosciences company (Chelmsford, Massachusetts), announced that it has received the 2008 Frost and Sullivan North American Technology Innovation Award in the field of integrated metabolomics systems.
ESA Biosciences, a Magellan Biosciences company (Chelmsford, Massachusetts), announced that it has received the 2008 Frost and Sullivan North American Technology Innovation Award in the field of integrated metabolomics systems. The award was presented to ESA’s Vice President of HPLC Products and Services, Ian Acworth, at the 2008 Growth Excellence Awards banquet on September 16 in San Francisco. According to Frost and Sullivan, ESA received the award for its leadership in developing an integrated platform based on HPLC with electrochemical-array detection, alone or in parallel with mass spectrometry.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.